MTHFR C677T/A1298C genotype: a possible risk factor for liver sinusoidal obstruction syndrome

被引：15
作者：
Efrati, E. [1 ,2 ,3 ]
Zuckerman, T. [4 ,5 ]
Ben-Ami, E. [1 ,2 ]
Krivoy, N. [1 ,2 ,3 ,5 ]
机构：
[1] Technion Israel Inst Technol, B Rappaport Inst Res Med Sci, Rappaport Rambam Ctr Translat Genet, Haifa, Israel
[2] Technion Israel Inst Technol, Fac Med, Haifa, Israel
[3] Clin Pharmacol Inst, Haifa, Israel
[4] Inst Hematol, Haifa, Israel
[5] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷 / 05期
关键词：
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; BUSULFAN PHARMACOKINETICS; GLUTATHIONE; TOXICITY; HOMOCYSTEINE; DISEASE; GENE; M1;
D O I：
10.1038/bmt.2014.16
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：726 / 727
页数：2
相关论文
共 11 条
  • [1] Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes
    DeLeve, LD
    Wang, XD
    [J]. PHARMACOLOGY, 2000, 60 (03) : 143 - 154
  • [2] Influence of Glutathione S-Transferase A1, P1, M1, T1 Polymorphisms on Oral Busulfan Pharmacokinetics in Children With Congenital Hemoglobinopathies Undergoing Hematopoietic Stem Cell Transplantation
    Elhasid, Ronit
    Krivoy, Norberto
    Rowe, Jacob M.
    Sprecher, Eli
    Adler, Lior
    Elkin, Hela
    Efrati, Edna
    [J]. PEDIATRIC BLOOD & CANCER, 2010, 55 (06) : 1172 - 1179
  • [3] A common mutation A1298C in human methylenetetrahydrofolate reductase gene: Association with plasma total homocysteine and folate concentrations
    Friedman, G
    Goldschmidt, N
    Friedlander, Y
    Ben-Yehuda, A
    Selhub, J
    Babaey, S
    Mendel, M
    Kidron, M
    Bar-On, H
    [J]. JOURNAL OF NUTRITION, 1999, 129 (09) : 1656 - 1661
  • [4] Goekkurt E, 2007, ANTICANCER RES, V27, P4377
  • [5] Pharmacokinetic and Pharmacogenetic Analysis of Oral Busulfan in Stem Cell Transplantation: Prediction of Poor Drug Metabolism to Prevent Drug Toxicity
    Krivoy, Norberto
    Zuckerman, Tsila
    Elkin, Hela
    Froymovich, Lia
    Rowe, Jacob M.
    Efrati, Edna
    [J]. CURRENT DRUG SAFETY, 2012, 7 (03) : 211 - 217
  • [6] Busulfan in hematopoietic stem cell transplant setting
    McCune, Jeannine S.
    Holmberg, Leona A.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (08) : 957 - 969
  • [7] VENO-OCCLUSIVE DISEASE OF THE LIVER AFTER BONE-MARROW TRANSPLANTATION - DIAGNOSIS, INCIDENCE, AND PREDISPOSING FACTORS
    MCDONALD, GB
    SHARMA, P
    MATTHEWS, DE
    SHULMAN, HM
    THOMAS, ED
    [J]. HEPATOLOGY, 1984, 4 (01) : 116 - 122
  • [8] SLATTERY JT, 1995, BONE MARROW TRANSPL, V16, P31
  • [9] Song JH, 2006, INT J ONCOL, V29, P57
  • [10] Glutathione S-transferase M1 polymorphism:: a risk factor for hepatic venoocclusive disease in bone marrow transplantation
    Srivastava, A
    Poonkuzhali, B
    Shaji, RV
    George, B
    Mathews, V
    Chandy, M
    Krishnamoorthy, R
    [J]. BLOOD, 2004, 104 (05) : 1574 - 1577
12